SECsense Logo

Editas Medicine, Inc. 8-K Report: Key Updates on Current Developments

$EDIT
Form 8-K
Filed on: 2024-12-17
Source
Editas Medicine, Inc. 8-K Report: Key Updates on Current Developments

Here are the key extracted insights from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Editas Medicine, Inc.
  • CIK: 0001650664
  • SEC File Number: 001-37687
  • EIN: 46-4097528
  • Address: 11 Hurley Street, Cambridge, MA 02141
  • Phone Number: 617-401-9000
  1. Filing Information:
  • Filing Type: 8-K (Current Report)
  • Filing Date: December 16, 2024
  1. Security Information:
  • Type of Security: Common Stock
  • Par Value: $0.0001 per share
  • Ticker Symbol: EDIT
  • Market: NASDAQ
  1. Financial Reporting Period:
  • Report Date: December 16, 2024 (the same as the filing date)

This report indicates a current filing by Editas Medicine, Inc., which may signify a significant event or update that necessitated the filing of an 8-K. Further details regarding the nature of the event would be necessary to provide additional context and implications for investors or stakeholders.